back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-12 17:05 Tx date 2025-06-10 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
152,447 | |
| Filed 2024-08-29 17:00 Tx date 2024-08-28 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
112,447 | |
| Filed 2023-06-12 17:16 Tx date 2023-06-07 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
72,447 | |
| Filed 2022-10-21 10:43 Tx date 2022-10-19 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$79,857
+15,000 vol $5.32 each |
15,000 | |
| Filed 2020-06-08 16:18 Tx date 2020-06-05 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
42,447 | |
| Filed 2019-05-22 16:36 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
27,447 | ||
| Filed 2019-05-22 16:36 Tx date 2019-05-13 |
$MIST
Milestone Pharmaceuticals Inc. |
Tomsicek, Michael John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|